Arterial hypertension is a common side effect of cyclosporine A therapy; however, the cellular mechanism of cyclosporine A-induced hypertension is still unknown. The present study, therefore, examined the effect of cyclosporine A 
T he clinical use of cyclosporine A (CyA) as an immunosuppressive agent has provided new perspectives in organ transplantation and the treatment of autoimmune diseases. The extensive use of CyA, however, has been accompanied by potentially severe side-effects. Although nephrotoxicity is the most common adverse effect, 1 arterial hypertension is also frequently reported and often requires treatment. 23 Functional hemodynamic alterations have been proposed to be involved in CyA nephrotoxicity, 4 and increased vascular resistance and contractility have been reported in heart transplant patients with CyA-associated hyperten-sion 5 and in CyA-treated rats. 6 It is, therefore, possible that CyA increases vascular smooth muscle tone and peripheral vascular resistance, thereby contributing to the development of hypertension.
Vascular smooth muscle tone may be increased by vasoconstrictor-induced rapid intracellular free Ca 2+ ([Ca 2+ ]j) mobilization in the initial phase and increased transmembrane Ca 2+ fluxes in the tonic phase of contraction. 78 In this regard, [Ca 2+ ]j concentration appears to be a major determinant of the force of the initial contractile process. 9 Although angiotensin, norepinephrine, and arginine vasopressin have different membrane receptors, their intracellular mechanisms mediating the contractile process are very similar and involve the same cellular processes. 10 The present study, therefore, was designed to investigate the potential interaction of CyA with one of these vasoconstrictors, namely arginine vasopressin, on Ca 2+ mobilization and contraction of cultured vascular smooth muscle cells. [Ca
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els and transmembrane Ca 2+ fluxes were measured and cell contraction was evaluated quantitatively with a digital imaging analysis system.
Materials and Methods
CyA, dissolved in cremophore, was obtained from Sandoz (Basel, Switzerland). The vehicle cremophore (Sigma Chemical Co., St. Louis, Missouri), a polyoxylated castor oil, was used in each control group in equivalent volumes. Arginine vasopressin was purchased from Bachem (Torrance, California). 45 Ca 2+ was purchased from ICN Radiochemicals (Irvine, California). Quin 2-acetoxy methylester (quin 2 AM) and quin 2-free acid were purchased from Sigma Chemical Co. Digitonin was obtained from Calbiochem (La Jolla, California). Dantrolene was a gift from Norwich Eaton (Norwich, New York).
Preparation of Aortic Smooth Muscle Cells and Cell Culture
Rat aortic smooth muscle cells were isolated by using a modified method originally described by Chamley et al. 11 The thoracic aortas were rapidly dissected out from decapitated male SpragueDawley rats (200-300 g) under sterile conditions. Each time, the aortas of six to eight rats were pooled. The surrounding adipose and connective tissues were then eliminated, and the aortas were incubated at 37° C for 30 minutes in 7.5 ml of Eagle's minimum essential medium (MEM) that contained 2 mg/ml collagenase (Cooper Biomedical, Malvern, Pennsylvania 218 units/mg). This treatment enabled the adventitia and small fragments of outer medium to be stripped off with watchmaker forceps under a dissecting microscope. The aortas were then cut longitudinally and the intima was scraped off. Then, the aortas were minced with sterile razor blades and incubated again at 37° C in Eagle's MEM that contained 2 mg/ml collagenase for 2.5-3.0 hours under continuous stirring. After this incubation, the resulting single-cell suspension was centrifuged for 5 minutes at 1,000 rpm. The cell pellet was resuspended in fresh incubation medium without collagenase. This procedure was repeated twice. The cells were plated onto 35-mm culture dishes at a density of 2.5-3.0X10 3 cells/dish and grown at 37° C in a humidified atmosphere of 95% air and 5% CO 2 . Eagle's MEM, supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 /itg/ml streptomycin, was used as culture medium. Cell viability was checked by the exclusion of trypan blue (0.3%) and always exceeded 95%. The cultures reached confluence after 7-10 days and were then used for experiments. We used only primary cultures for these studies because vascular smooth muscle cells lose their contractility when subcultured. 12 Cell identity and culture homogeneity were examined by electron microscopy in several different cultures of vascular smooth muscle cells. (13 mm) in MEM with 10% fetal bovine serum. On confluence, the cover slips were washed twice with MEM without fetal bovine serum. Cells were then incubated for 60 minutes at 37° C with 1 ml of serum-free MEM that contained 15 ^iM quin 2 AM. At the end of the loading period, the cover slips were washed three times and preincubated with either cremophore or CyA for 10 minutes in physiological saline solution (PSS) (NaCl 140 mM, KC1 4.6 mM, MgCl 2 1.0 mM, CaCl 2 1.0 mM, glucose 10.0 mM, HEPES 10.0 mM, and pH 7.4). Then the coverslips were rinsed again with PSS and inserted into cuvettes containing 3 ml PSS. The cuvettes were placed in the thermostated holder of a Perkin-Elmer (650-1 OS, Norwalk, Connecticut) fluorescence spectrophotometer that faced both the oncoming beam and the detector at an angle of 45°. Fluorescence of the quin 2-loaded monolayers was measured with an excitation wavelength of 339 nm (5 nm slit) and ah emission wavelength of 492 nm (15-20 nm slit). 13 The complete intracellular hydrolysis of quin 2 AM was judged by scanning the emission spectrum of quin 2 from 400 to 600 nm in the loaded cells. The cells exhibited a complete spectral shift that peaked at 490-500 nm at the end of the loading procedure. A slow spontaneous decrease in fluorescence emission of quin 2-loaded cells (9.3±0.5%, mean±SEM, n=\\, of total Ca 2+ -dependent fluorescent emission) after 2 minutes was observed due to photo bleaching of the probe, and calculations of basal and peak [Ca 2+ ]j were corrected accordingly. A value of 115 nM was used as the dissociation constant (A^) of the quin 2-Ca 2+ complex. 13 
Measurements of Intracellular
[Ca
2+
]i was calculated by using the following equation 15 :
where F is the fluorescence intensity of the cytoplasmic dye within the cells. F^ was measured by treating the cells with 5xlO" 5 M digitonin.
14 Leakage of quin 2 from the cells was excluded by adding 5x 10~4 MnCl 2 to quench the fluorescence of any extracellular quin 2. This maneuver did not affect the basal fluorescence.
45
Ca
2+
Efflux
The culture medium was removed by aspiration of cell monolayers, which were then rinsed twice with PSS and loaded with 8 jiCi of 45 
Ca
2+ in 1 ml of PSS at 37° C for 3 hours. Then the cultures were rapidly rinsed 10 times (45 seconds total) with 1 ml PSS, and another 1 ml of PSS was added. The medium was removed and replaced with 1 ml of PSS at 1, 2, 3, and 4 minutes and at 30-second intervals thereafter. for 10 minutes before the start of the experiment.
45
Ca 2+ extruded from the cells in each time interval was measured by liquid scintillation counting. Intracellular radioactivity was extracted with 1 ml sodium dodecyl sulfate (SDS) that contained alkaline solution (1% SDS, 2% Na 2 CO 3 , OAN NaOH). -free PSS that contained 2 mM EGTA. Intracellular radioactivity was extracted with SDS alkaline solution and measured by liquid scintillation counting. Protein was determined in all studies by the method of Lowry et al. 15 
Smooth Muscle Cell Contraction
The contractile response of aortic smooth muscle cells was evaluated by using phase contrast microscopy (IM, Zeiss, Oberkochen, FRG) and a digital imaging analysis system (Zidas, Zeiss). The digitizer was calibrated with a micrometer scale for each experiment. Cell surface area was measured before and 20 minutes after the addition of any agent. These measurements were done in duplicate ( Figure 4 ) and triplicate ( Figure 5 ) on each cell. Repeated measurements of the same cell yielded an average coefficient of variation of approximately 1.5%. As opposed to other cell types like fibroblasts, vasopressor-induced shortening of cell dimensions in the smooth muscle cell is mediated by specific receptors and represents a physiological response. Thus, the change of cell shape associated with a decrease of cell surface area was considered the cellular equivalent to smooth muscle contraction in vivo. Taking into account the spontaneously occurring change of cell shape and the variability in the image analysis, only a decrease in cell surface area of more than 15% was considered a positive contractile response. A x20 objective was used for all contraction studies. The microscopic field was chosen randomly and not selected for cell shape or size. Only cells with easily discernible boundaries were used for measurement. At the time of the experiment, culture medium was aspirated, and cells were washed twice with PSS. Cells were then incubated in PSS with either cremophore or CyA for 10 minutes. Neither cremophore nor CyA had any effect on cell morphology. Cell surface area was then measured directly before and 20 minutes after the addition of arginine vasopressin. The contraction studies were carried out at room temperature.
Statistical Analysis
Data are presented as mean±SEM and statistical analysis was performed with the Student's t test for paired and unpaired data. The Bonferroni correction was used for multiple comparisons. Cell contraction was evaluated with the WUcoxon rank sum test. ]j rose from 5O±3% to 101 ±3% (p<0.05) ( Table 2 ) with 5 /xg/ml CyA and to 118±4% (p<0.01) with 10 /xg/ml CyA. Pretreatment with cremophore did not affect 
Results
Intracellular
Ca
2+ efflux studies were carried out to evaluate whether CyA-induced enhancement of arginine vasopressin-stimulated Ca 2+ mobilization might be associated with alterations of Ca 2+ extrusion from the cell. Spontaneous Ca 2+ efflux was measured as described after preincubation with cremophore. The efflux rate decreased rapidly during the first few minutes, and the further decline was then considerably slower ( Figure 1 ). Cremophore did not affect efflux when compared with cells preincubated in the absence of the CyA vehicle (data not shown). Preincubation with CyA did not affect spontaneous Ca 2+ efflux. Figure 1 (Figure 2 ). Within 3 minutes, efflux returned to prestimulated levels. Pretreatment (10 minutes) with CyA greatly enhanced the stimulatory effect of arginine vasopressin; the peak efflux rate, which was also reached after 60 seconds, was significantly higher than with arginine vasopressin alone (p<0.005). The pattern of the efflux curve was not affected, but after 3 minutes efflux rates were still above levels observed with arginine vasopressin alone. As shown in Figure 2A , the effect of CyA was dose dependent; CyA 5 /ig/ml was much less effective than CyA 10 /£g/ml. CyA had no effect when added simultaneously with arginine vasopressin (data not shown).
As shown in Figure 2B , arginine vasopressin also stimulated Ca 2+ efflux in Ca
2+
-free medium to the same extent as it did in Ca 2+ -containing medium, although in this series of experiments basal efflux rates were somewhat higher. Furthermore, the augmentory effect of CyA on arginine vasopressininduced Ca 2+ efflux was not changed in the absence of extracellular Ca 2+ . The differential increment after 30 seconds was 550±214 cpm/mg prot/30 sec in untreated and 2,124±508 cpm/mg prot/30 sec in CyA-treated cells (p<0.001).
Dantrolene, an inhibitor of sarcoplasmic Ca 2+ release, 17 blocked the stimulatory effect of arginine vasopressin on * 3 Ca 2+ efflux ( Figure 2C ). In the presence of CyA and dantrolene, however, a significant but attenuated increase in arginine vasopressininduced efflux was still observed (792±115 vs. l,204±151 cpm/mg prot/30 sec, p<0.001) ( Figure  2C) 
10.99±0.59x 10
3 cpm/mg prot/5 min, NS), and verapamil alone did not affect Ca 2+ uptake ( Figure 3B ).
Smooth Muscle Cell Contraction
Contraction studies were undertaken to correlate the results from the Ca 2+ flux studies with the morphological response. Aortic smooth muscle cells incubated in PSS retained their flat and spindle-shape appearance with prominent processes. On addition of arginine vasopressin to the incubation medium, cells showed contraction beginning after 3-5 minutes. Contraction was maximal after about 20 minutes. Contracted cells lost their flat appearance and showed an average decrease in cell surface area of approximately 30% and retraction of cell processes. The decrease in cell surface area did not change significantly with different doses of arginine vasopressin, but the percentage of cells contracting was clearly dose dependent ( Figure 4 ). Figure 5 depicts the effect of 10 /xg/ml CyA on arginine vasopressininduced cell contraction; CyA significantly enhanced contraction elicited by 10~8 M arginine vasopressin (25.5±1.1% vs. 38.2±1.2%, p<0.05); the enhancement of 10~7 M arginine vasopressin-stimulated contraction by CyA was also significant (32.8±1.6% vs. 39.9±1.9%,p<0.05).
Discussion
The effect of CyA to cause hypertension, and thus potentially contribute to cardiovascular disease in those patients receiving this form of immunosuppression for long periods, is a matter of concern. CyA-induced hypertension appears to be primarily related to an increase in peripheral vascular resistance and has been found to occur in heart transplant patients in the absence of increase in circulating concentrations of vasoconstrictors such as norepinephrine and angiotensin. 518 These latter findings are compatible with an effect of CyA to enhance the vasoconstrictor response to such endogenous pressor agents rather than increasing their release. Most recently, published findings demonstrating increased renal vascular resistance in response to norepinephrine in the presence of CyA are in support of this potential mechanism. 19 Although the three major endogenous vasoconstrictors (angiotensin, norepinephrine, and arginine vasopressin) are known to have separate membrane receptors on smooth muscle, their subsequent intracellular mechanism initiating the contractile process appears to be quite similar. 10 Because of the interest of our laboratory in the vascular efiFect of arginine vasopressin, 20 we chose this agent to study the possibility that CyA may alter the response of vascular smooth muscle to endogenous pressor hormones. Even if these vasopressors are only found in subpressor concentrations in vivo, a potentiating interaction between these endogenous hormones and CyA at the cellular level may increase smooth muscle contraction and thus peripheral vascular resistance. A positive interaction of arginine vasopressin and angiotensin II at the cellular level has recently been demonstrated in vascular smooth muscle cells. 21 The initial contractile response to arginine vasopressin and other vasoconstrictors involves a rapid mobilization of [Ca 2+ ]j from the sarcoplasmic reticulum, an effect that is associated with a rapid rise in [Ca 2+ ]i, efflux of Ca 2+ from the cell and then a rapid return of [Ca 2+ ]| to baseline concentrations. 22 - 23 The use of fluorescent dyes and 45 
Ca
2+ flux studies have allowed this "trigger" event of contraction to be studied in vitro using vascular smooth muscle cells in culture. In the present in vitro study, concentrations of arginine vasopressin and CyA are considerably higher than those seen in vivo. Interpretations of the present results, relative to the in vivo circumstance, must therefore be made with extreme caution. It is of note, however, that arginine vasopressin concentrations in the micromolar to nanomolar range are widely used in cell culture systems 22 -24 -26 and CyA concentrations applied in the present study have also been used previously in isolated hepatocytes. 26 In spite of the acknowledged limitations, such studies on cell cultures may provide insight into basic pathophysiological mechanisms underlying the adverse effects of CyA. As mentioned above, there is recent experimental evidence that the proposed cellular mechanisms may indeed be active in vivo. 19 In the present study, CyA enhanced in a doseresponse manner the rapid increase in [Ca 2+ ]j that occurred with arginine vasopressin, as assessed by measurements with quin 2. Results from our laboratory and others 
2+ influx, an event associated with the sustained phase of contraction and thus perhaps the activation of protein kinase C. These observations are again comparable with the findings in hepatocytes. 26 However, in contrast to no observed effect of CyA on [Ca 2+ ]i and 43 
2+ efflux in the absence of arginine vasopressin, CyA increased cellular 45 
2+ influx in the absence of arginine vasopressin. This effect was not abolished by verapamil, a blocker of potential-activated Ca 2+ channels. A direct effect of CyA on plasma membrane permeability to Ca 2+ influx might be enhanced. Such an interpretation is compatible with the observation that CyA is known to increase cellular thromboxane A 2 production, a known product of membrane phospholipid metabolism. 28 The present in vitro studies are compatible with the following sequence of events: CyA increases Ca 2+ membrane permeability through nonpotential activated channels, and thus leads to an increase in Ca 2+ stores. ]j is not increased in the presence of CyA. An effect of CyA to increase the percentage of cells that contract in response to arginine vasopressin, as assessed by digital imaging analysis, was associated with these effects of CyA to alter cellular Ca 2+ kinetics in response to arginine vasopressin. Since the contractile effects of angiotensin II and norepinephrine are mediated by similar cellular events, it seems likely that CyA would not only enhance the contractile effect of arginine vasopressin but also angiotensin II and norepinephrine. The results of these in vitro experiments are therefore compatible with the hypertensive effect of CyA to occur secondary to an enhancement of the action of vasopressors on vascular smooth muscle, thus increasing peripheral vascular resistance and raising blood pressure in the absence of increases in plasma concentrations of these endogenous pressor hormones.
